The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation

Journal of Invasive Cardiology

Volumn 25, Issue 1, 2013, Pages 38-44

  Elhmidi, Yacine ^a   Bleiziffer, Sabine ^a   Piazza, Nicolo ^a   Ruge, Hendrik ^a   Krane, Markus ^a   Deutsch, Markus André ^a   Hettich, Ina ^a   Voss, Bernhard ^a   Mazzitelli, Domenico ^a   Lange, Rüdiger ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

biomarkers in TAVI; NT proBNP; prognostic value of BNP; TAVI

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL READMISSION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT IDENTIFICATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ATRIAL FIBRILLATION; BALLOON VALVULOPLASTY; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84872298140     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dickstein K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. Reply. Eur Heart J. Epub 2008 Dec 24.
2. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109(19):2302-2308.
3. Patel DN, Bailey SR. Role of BNP in patients with severe asymptomatic aortic stenosis. Eur Heart J. 2004;25(22):1972-1973.
4. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J. 2005;26(10):1023-1030.
5. Nozohoor S, Nilsson J, Luhrs C, Roijer A, Algotsson L, Sjogren J. B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement. J Cardiothorac Vasc Anesth. 2009;23(2):161-165.
6. Kolh P, Lahaye L, Gerard P, Limet R. Aortic valve replacement in the octogenarians: perioperative outcome and clinical follow-up. Eur J Cardiothorac Surg. 1999;16(1):68-73.
7. Spargias K, Alexopoulos E, Thomopoulou S, et al. Effect of balloon valvuloplasty in patients with severe aortic stenosis on levels of N-terminal pro-B-type natriuretic peptide. Am J Cardiol. 2009;104(6):846-849.
8. Bleiziffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3(5):524-530.
9. Berry C, Asgar A, Lamarche Y, et al. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc In-terv. 2007;70(4):610-616.
10. Berger R, Stanek B, Frey B, et al. B-type natriuretic peptides (BNP and PRO-BNP) predict longterm survival in patients with advanced heart failure treated with atenolol. J Heart Lung Transplant. 2001;20(2):251.
11. Pedrazzini GB, Masson S, Latini R, et al. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol. 2008;102(6):749-754.
12. Weber M, Hausen M, Arnold R, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis. Heart. 2006;92(11):1639-1644.
13. Sherif MA, Abdel-Wahab M, Awad O, et al. Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation. Am Heart J. 2010;160(5):862-869.
14. Bergler-Klein J, Mundigler G, Pibarot P, et al. B-type natriuretic peptide in low-fow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation. 2007;115(22):2848-2855.
15. Neverdal NO, Knudsen C W, Husebye T, et al. The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis - one year follow-up. Eur J Heart Fail. 2006;8(3):257-262.
16. Georges A, Forestier F, Valli N, Plogin A, Janvier G, Bordenave L. Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. Eur J Cardiothorac Surg. 2004;25(6):941-945.
17. Qi W, Mathisen P, Kjekshus J, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J. 2001;142(4):725-732.
18. Yamada T, Murakami Y, Okada T, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide levels after radiofrequency catheter ablation of atrial fbrillation. Am J Cardiol. 2006;97(12):1741-1744.
19. Qi W, Mathisen P, Kjekshus J, et al. The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis. Clin Cardiol. 2002;25(4):174-180.
20. Kefer J, Beauloye C, Astarci P, et al. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation. Am J Cardiol. 2010;106(12):1782-1786. Epub 2010 Nov 3.
21. Gerber IL, Stewart RA, Legget ME, et al. Increased plasma natriuretic peptide levels refect symptom onset in aortic stenosis. Circulation. 2003;107(14):1884-1890.
22. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50(25):2357-2368.
23. Iwanaga Y, Nishi I, Furuichi S, et al. B-type natriuretic peptide strongly refects dia-stolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol. 2006;47(4):742-748.
24. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol. 2004;94(6):740-745.
25. Batal O, Faulx M, Krasuski RA, et al. Effect of obesity on B-type natriuretic peptide levels in patients with pulmonary arterial hypertension. Am J Cardiol. 2012;110(6):909-914. Epub 2012 Jun 7.
26. Tay EL, Gurvitch R, Wijesinghe N, et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011;4(12):1290-1297.
27. Hussein AA, Saliba WI, Martin DO, et al. Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fbrillation. Circulation. 2011;123(19):2077-2082.